Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Celgene Corporation    CELG

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets
Latest Tweets
10:59aHoran Capital Advisors LLC. Has $3.64 Million Holdings in Celgene Corporation.. 
10/16Celgene Corporation's buy rating reiterated at Jefferies Group LLC. $160.00 P.. 
10/16Celgene Corporation given $162.00 PT by Cantor Fitzgerald. buy rating.
1
10/16Celgene Corporation : Today's Research Reports on Stocks to Watch: Celgene Co.. 
10/16$CELG Results from Phase 2 Studies of Oral Ozanimod in Crohn's Disease and Ul.. 
10/16Celgene Corporation $CELG Price Target Raised to $140.00  
10/16Celgene Corporation $CELG Position Lifted by Fiduciary Financial Services of .. 
10/16Schwab Charles Investment Management Inc. Raises Holdings in Acceleron Pharma.. 
10/15Brokerages Set Acceleron Pharma Inc. $XLRN Price Target at $44.64  
10/15Celgene Corporation $CELG Holdings Decreased by BRITISH COLUMBIA INVESTMENT M.. 
10/15$CELG - Alpine Woods Capital Investors LLC Invests $1.10 Million in Celgene C.. 
10/15$CELG - Ridgewood Investments LLC Maintains Position in Celgene Corporation #.. 
10/14$CELG Information for Celgene Corporation From our Stock News Alerts App 
10/14United Asset Strategies Inc. Takes Position in Celgene Corporation $CELG  
10/14Celgene Corporation $CELG Position Raised by Abbrea Capital LLC  
10/13Acceleron Pharma Inc. $XLRN Shares Bought by Tudor Investment Corp ET AL  
10/13Investors Buy Celgene Corporation $CELG on Weakness  
10/13Celgene's Steady Progression  
10/12SWING TRADE ALERT: Recent $CELG technical alerts: Calm After Storm plus 10 mo.. 
10/12Acceleron Pharma initiated by HC Wainwright at buy. $57.00 PT.  
10/12H.C. Wainwright Believes Acceleron Pharma (NASDAQ: XLRN) Still Has Room to Gr.. 
10/12Celgene Corporation $CELG Shares Sold by Adirondack Trust Co.  
10/11RECAP 10/11 +Chatter: $ARNC $CELG -Chatter:
1
10/10Strategic Research Analysis ­ Positioning to Benefit on  Abbott, Rite Aid, Kr.. 
10/10ValuEngine Upgrades Alliqua BioMedical, Inc. $ALQA to Hold  
10/10Granite Investment Partners LLC Sells 3 Shares of Celgene Corporation $CELG  
10/10Evotec Achieves First Milestone in Neurodegeneration Alliance with Celgene  
10/10BRIEF-Evotec achieves first milestone in neurodegeneration alliance with Celg.. 
10/10Evotec Achieves First Milestone in Neurodegeneration Alliance with Celgene: H.. 
10/10Evotec Achieves First Milestone in Neurodegeneration Alliance with Celgene  
10/10BRIEF-Evotec receives $5 million milestone in Celgene alliance  
10/10EVOTEC ACHIEVES FIRST MILESTONE IN NEURODEGENERATION ALLIANCE WITH CELGENE  
10/10Somewhat Favorable Press Coverage Somewhat Unlikely to Impact Celgene Corpora.. 
10/10Heaps Of Healthy Health Care ETFs  
10/09Why @JimCramer says don’t ignore the oldest rule in the game when it comes to..
2
10/09In today's drug price increase news, $CELG takes smaller-than-usual increases..
9
10/09$CELG - Celgene Corporation #CELG Holdings Raised by Canada Pension Plan Inve.. 
10/09Celgene Corporation $CELG Raised to Buy at Vetr Inc.  
10/09Celgene Corporation $CELG Holdings Cut by Morse Asset Management Inc  
10/09Oppenheimer Holdings Weighs in on Acceleron Pharma Inc.’s Q3 2017 Earnings $X.. 
10/08Celgene Corporation $CELG Cut to “Underweight” at Morgan Stanley  
10/08Acceleron Pharma Inc. $XLRN Stock Rating Lowered by ValuEngine  
10/08$CELG - Celgene Corporation #CELG Shares Sold by Legacy Capital Partners Inc... 
10/08$CELG - HL Financial Services LLC Has $615,000 Stake in Celgene Corporation #.. 
10/08Global X Management Co. LLC Grows Stake in Celgene Corporation $CELG  
10/08Global X Management Co. LLC Grows Stake in Celgene Corporation $CELG  
10/08Stock Traders Buy Large Volume of Celgene Corporation Put Options $CELG  
10/08$CELG - Analysts Set Celgene Corporation #CELG Target Price at $151.29  
10/07$CELG Information for Celgene Corporation From our Stock News Alerts App 
10/07Celgene Corporation $CELG Stock Rating Reaffirmed by Royal Bank Of Canada  
More tweets
Qtime:471
Financials ($)
Sales 2017 13 248 M
EBIT 2017 7 532 M
Net income 2017 4 348 M
Debt 2017 3 768 M
Yield 2017 -
P/E ratio 2017 24,24
P/E ratio 2018 18,71
EV / Sales 2017 8,36x
EV / Sales 2018 6,84x
Capitalization 107 B
Chart CELGENE CORPORATION
Duration : Period :
Celgene Corporation Technical Analysis Chart | CELG | US1510201049 | 4-Traders
Technical analysis trends CELGENE CORPORATION
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 27
Average target price 155 $
Spread / Average Target 13%
EPS Revisions
Managers
NameTitle
Mark J. Alles Chief Executive Officer & Director
Scott Andrew Smith President & Chief Operating Officer
Robert J. Hugin Executive Chairman
Peter N. Kellogg Chief Financial Officer & Executive Vice President
Joseph S. Camardo Senior Vice President-Global Medical Affairs
Sector and Competitors
1st jan.Capitalization (M$)
CELGENE CORPORATION17.89%106 955
JOHNSON & JOHNSON18.42%365 346
NOVARTIS13.23%226 956
ROCHE HOLDING LTD.5.20%215 359
PFIZER11.88%214 265
MERCK AND COMPANY7.68%172 751